Cabaletta Bio Reports Third Quarter 2024 Financial Results and Provides Business Update
Provided By GlobeNewswire
Last update: Nov 14, 2024
– Clinical data from the RESET-Myositis™ and RESET-SLE™ trials, along with initial clinical data from the RESET-SSc™ trial, to be presented this weekend in oral and poster presentations at ACR Convergence 2024 –
Read more at globenewswire.com1.87
-0.04 (-2.09%)
Find more stocks in the Stock Screener
CABA Latest News and Analysis
16 days ago - ChartmillTop movers in Friday's pre-market sessionDiscover the top movers in Friday's pre-market session and stay informed about market dynamics.
17 days ago - ChartmillThese stocks are gapping in today's sessionTraders are paying attention to the gapping stocks in Thursday's session. Let's dive into which stocks are experiencing notable gaps.
